MedTrace Logo

B-Receptor Signaling in Cardiomyopathy

NCT01135849 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 99

Last updated 2015-11-17

No results posted yet for this study

Summary

We hope to determine the importance of different genes (including B receptors) in anthracycline-induced cardiomyopathy. This has important benefits to patients exposed to anthracyclines, as this could help determine whether certain individuals have increased susceptibility to cardiac injury.

Conditions

Sponsors & Collaborators

  • Daniel Bernstein

    lead OTHER

Principal Investigators

  • Daniel Bernstein · Stanford University

Eligibility

Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01135849 on ClinicalTrials.gov